New & Improved!

Submit a New & Noteworthy
October 2010
Automated IV Compounding
By: McKesson US Pharma & Specialty

McKesson announces the availability of Health Robotics’ CytoCare, an automated system for compounding hazardous IVs used in chemotherapy, monoclonal antibody therapy, and genetic therapy. The system helps hospital pharmacies increase accuracy, reduce manual errors, and improve efficiencies when preparing hazardous IVs. Automating the process of compounding IVs decreases injury and exposure risks by protecting pharmacy staff from product selection and measurement errors, as well as from needle stick injuries.

Click here to view product detail on Findit.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register:

    As of May 24, 2018, www.pppmag.com's Terms of Use and Privacy Policy have been updated.
    You can review the Terms of Use HERE and the Privacy Policy HERE.
    By continuing to use www.pppmag.com, you are agreeing to these changes.